NCT04738422View on ClinicalTrials.gov

Determining Airway PH by Compartmental Exhaled Nitric Oxide Levels During Alkaline Buffer Challenge

PHASE2Enrolling by invitationINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 11, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Airway Disease
Interventions
DRUG

Alkaline glycine

Subjects will inhale alkaline glycine via nebulizer. Alkaline glycine is an alkaline medication designed for medication.

Trial Locations (1)

46219

Indiana University School of Medicine, Indianapolis

All Listed Sponsors
lead

Indiana University

OTHER